The grant allows a team to spend the next three years trying to unlock the blood brain barrier to allow drugs to be targeted at diseases including cancer. The £451,000 grant was given by the Biotechnology and Biological Sciences Research Council.
Drugs already exist that can be successfully used against some diseases elsewhere in the body but when those diseases are in the brain they are much harder to treat because most drugs cannot penetrate the protective barrier.
Dr Eugen Barbu, a chemist, will lead a team of four scientists from the School of Pharmacy aiming to modify a natural polymer so it can temporarily create an opening in the blood brain barrier and get through to deliver medicine. They will use polymer-based nanoparticles that are approximately 1/1000 of the diameter of a single human hair, which is about 80,000 nanometres wide.
The modified polymer would be small enough to breach the blood brain barrier and would act like a delivery container carrying the drug. Once they deliver their drug load to the brain they would biodegrade. A novel living 3D cell culture model of the human blood-brain barrier will be used to initially screen the interaction between the nanoparticles and the brain.
The research team chose to study natural polymers because they make excellent drug-carriers, are non-toxic and are biodegradable and biocompatible, so the brain won’t reject them.
Prof Darek Gorecki will be working alongside Dr Barbu. He said: “The BBSRC thought it was worth investing half a million pounds because though other scientists are studying ways of penetrating the blood brain barrier this idea of using modified natural polymers is novel.
“It is very experimental at this stage and the distance from here to doctors being able to better treat brain tumours is a long way off.
“The brain relies upon a rich blood supply but the barrier exists because it is vital not everything in the blood can get through. It is a very sophisticated filter. We are hoping that by using modified polymers working in various ways we can generate a temporary opening in the cells of the blood brain barrier and allow drugs to be delivered straight to the brain.”
If successful, the temporary unlocking of the filter would allow a range of brain diseases to be treated more efficiently. It is hoped that in the long term these formulations will be useful for the treatment of a range of brain diseases including brain tumours, stroke and neurodegenerative disorders.
The research group comprises a multidisciplinary team of Dr Barbu, senior research fellow, Dr John Tsibouklis, reader in polymer science, Professor Geoffrey Pilkington, a professor of cellular and molecular neuro-oncology and world-renowned expert in brain tumour biology and pathology, and Prof Gorecki, professor of molecular medicine. The team work in the Institute of Biomedical and Biomolecular Science, Biomaterials and Bionanotechnology and Cellular and Molecular Medicine Groups at the university, and will be supported by two post-doctoral researchers.
Kate Daniell | alfa
New nanomedicine slips through the cracks
24.04.2019 | University of Tokyo
Sugar entering the brain during septic shock causes memory loss
23.04.2019 | Rensselaer Polytechnic Institute
For the first time, physicists at the University of Basel have succeeded in measuring the magnetic properties of atomically thin van der Waals materials on the nanoscale. They used diamond quantum sensors to determine the strength of the magnetization of individual atomic layers of the material chromium triiodide. In addition, they found a long-sought explanation for the unusual magnetic properties of the material. The journal Science has published the findings.
The use of atomically thin, two-dimensional van der Waals materials promises innovations in numerous fields in science and technology. Scientists around the...
Flexible, organic and printed electronics conquer everyday life. The forecasts for growth promise increasing markets and opportunities for the industry. In Europe, top institutions and companies are engaged in research and further development of these technologies for tomorrow's markets and applications. However, access by SMEs is difficult. The European project SmartEEs - Smart Emerging Electronics Servicing works on the establishment of a European innovation network, which supports both the access to competences as well as the support of the enterprises with the assumption of innovations and the progress up to the commercialization.
It surrounds us and almost unconsciously accompanies us through everyday life - printed electronics. It starts with smart labels or RFID tags in clothing, we...
The human eye is particularly sensitive to green, but less sensitive to blue and red. Chemists led by Hubert Huppertz at the University of Innsbruck have now developed a new red phosphor whose light is well perceived by the eye. This increases the light yield of white LEDs by around one sixth, which can significantly improve the energy efficiency of lighting systems.
Light emitting diodes or LEDs are only able to produce light of a certain colour. However, white light can be created using different colour mixing processes.
Researchers led by Francesca Ferlaino from the University of Innsbruck and the Austrian Academy of Sciences report in Physical Review X on the observation of supersolid behavior in dipolar quantum gases of erbium and dysprosium. In the dysprosium gas these properties are unprecedentedly long-lived. This sets the stage for future investigations into the nature of this exotic phase of matter.
Supersolidity is a paradoxical state where the matter is both crystallized and superfluid. Predicted 50 years ago, such a counter-intuitive phase, featuring...
A stellar flare 10 times more powerful than anything seen on our sun has burst from an ultracool star almost the same size as Jupiter
17.04.2019 | Event News
15.04.2019 | Event News
09.04.2019 | Event News
26.04.2019 | Physics and Astronomy
26.04.2019 | Life Sciences
26.04.2019 | Physics and Astronomy